A&P boosts flu program
MONTVALE, N.J. —In light of the heightened concerns this cold and flu season, pharmacy retailers are bolstering their efforts to keep customers healthy, and A&P’s family of supermarkets is no exception.
The company—along with its banner stores A&P, Pathmark, Super Foodmart, Superfresh and Waldbaum’s—has developed a new flu vaccine program that enables shoppers to obtain free and discounted seasonal and H1N1 (when available) flu vaccinations.
A&P has teamed up with ESI Medical for the implementation of a series of multistate flu vaccination clinics that will run through Dec. 23. In total, A&P is hosting more than 600 flu vaccination clinics, offering seasonal and H1N1 (when available) flu vaccinations in 250 stores throughout six states. ESI Medical is a physician-owned home care agency that specializes in live-in and hourly care, and vaccinations for flu, shingles and travel.
In addition, the retailer is offering a buy one, get one free flu shot promotion. Through this new campaign, customers who use their Club Card through Oct. 29, and spend $100 on health-and-beauty care products (excluding baby items), will receive a Wellness Reward Certificate good for one free flu vaccination upon the purchase of an accompanying flu shot at $30. Any A&P shopper receiving a flu shot at an in-store clinic will receive a coupon book with savings on hundreds of cough, cold-flu, grocery, nonfoods and health items.
Hy-Vee celebrates the other white meat
WEST DES MOINES, Iowa A lot of people complain about pork barrel spending, but not Midwest supermarket chain Hy-Vee.
October is National Pork Month, and the West Des Moines, Iowa-based Hy-Vee announced Friday that sales of the meat have increased more than 25% over October 2008. The chain said it was on track to increase pork tonnage by more than 30%.
“With pork prices the lowest they’ve been in more than a decade, we’ve focused our marketing efforts on promoting pork as a great value for consumers,” Hy-Vee assistant VP meat operations Kenan Judge said in a statement. “Today’s shopper is looking for nutritious, economical meal ideas, and pork perfectly fits the bill.”
Patients prefer new diabetes drug Victoza over its competitor, survey finds
MONTREAL A new diabetes drug satisfied patients more than its competitor, according to a study funded by the drug’s manufacturer.
According to data on 379 patients who took the Diabetes Treatment Satisfaction Questionnaires, presented Thursday at the 20th World Diabetes Congress and published in medical journal The Lancet, patients taking Novo Nordisk’s drug Victoza (liraglutide) perceived less abnormally low or high blood sugar levels — known respectively as hypoglycemia and hyperglycemia — than those taking Byetta (exenatide), made by Eli Lilly & Co., Amylin Corp. and Alkermes.
Victoza is approved in Europe, but Novo Nordisk is still waiting for approval from the Food and Drug Administration in the United States.
“Liraglutide has shown here in a convincing study that it is associated with less nausea, less perceived hypoglycemia and definitely higher patient satisfaction compared to exenatide,” principal investigator Wolfgang Schmidt said in a statement. “Patient-reported outcomes data is an important extension of the efficacy data. If a patient is satisfied with his or her treatment, then they are much more likely to really stick to the treatment over the long term, which is necessary in Type 2 diabetes.”